Innovex International officer proposes $523K share sale

Available on EDGAR 11/12/2026 - 04:01 PM EST Accepted by SEC EDGAR 11/12/2026 - 04:00 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Innovex International, Inc. (INVX) lists Reed Kendal, an officer, as proposing to sell 20,868 common shares, with an aggregate market value of $522,528.46 and an approximate sale date of November 12, 2026. The notice lists issuer stock awards of 12,557 shares acquired January 1, 2024, and 8,311 shares acquired July 3, 2024. UBS Financial Services Inc. signed as attorney-in-fact for Kendal Reed.

Key Figures

Common shares proposed for sale: 20,868 shares Aggregate market value: $522,528.46 Common shares outstanding: 70,107,908 shares +2 more

5 metrics

Common shares proposed for sale 20,868 shares Proposed sale by Reed Kendal, an officer of Innovex International, Inc.

Aggregate market value $522,528.46 For the 20,868 common shares proposed for sale

Common shares outstanding 70,107,908 shares Innovex International, Inc.

Shares acquired in stock award 12,557 shares Issuer stock award acquired January 1, 2024

Shares acquired in stock award 8,311 shares Issuer stock award acquired July 3, 2024

Key Terms

Rule 10b5-1, Stock Award, Aggregate Market Value

3 terms

Rule 10b5-1 regulatory

"If Relying on Rule 10b5-1"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

Stock Award financial

"Nature of Acquisition Transaction: Stock Award"

Aggregate Market Value financial

"Aggregate Market Value"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many INVX shares does officer Reed Kendal propose to sell?

The proposed sale is 20,868 common shares, with an aggregate market value of $522,528.46 and an approximate sale date of November 12, 2026.

How did Reed Kendal acquire the INVX shares listed for sale?

The notice lists two issuer stock awards: 12,557 shares acquired January 1, 2024, and 8,311 shares acquired July 3, 2024.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002025606
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Innovex International, Inc.
SEC File Number	001-13439
Address of Issuer	19120 KENSWICK DRIVE HUMBLE TEXAS 77338
Phone	3463980000
Name of Person for Whose Account the Securities are To Be Sold	Reed Kendal
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services Inc. 11 Madison Avenue 4th Floor New York NY 10010	20868	522528.46	70107908	11/12/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/01/2024	Stock Award	Issuer			12557	01/01/2024	N/A
Common	07/03/2024	Stock Award	Issuer			8311	07/03/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	11/12/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/13/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc, as attorney-in-fact for Kendal Reed
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)